medigraphic.com
ISSN 2078-7170 (Electronic)

2022, Number 2

<< Back Next >>

CorSalud 2022; 14 (2)

Metabolic syndrome and cardiovascular risk in pre-eclampsia

Suárez GJA, Gutiérrez MM, Álvarez-Guerra GE, Sarasa MNL, Cañizares LO

Language: Spanish
References: 21
Page: 173-178
PDF size: 256.54 Kb.


ABSTRACT

Introduction: Metabolic syndrome and insulin resistance are predictors of cardio-vascular risk in pregnancy.
Objective: To determine the presence of metabolic syndrome in pre-eclampsia and its relationship with cardiovascular risk.
Method: Descriptive, prospective, observational, cross-sectional study was car-ried out with 180 pregnant women, from 2019 to 2020. Body mass index was calcu-lated, blood pressure was measured and the diagnosis of metabolic syndrome was established, according to the existing criteria. Triglyceride, HDL cholesterol and blood glucose concentrations were quantified. Data were processed with SPSS v. 20.0 statistical software.
Results: Seventy-three of the 180 pregnant women developed pre-eclampsia, in whom serum HDL cholesterol levels lower than 1.29 mmol/L (84.93%) predomi-nated; as well as triglyceride levels greater than 1.7 mmol/L (67.12%), and abdomi-nal circumference greater than 88 cm (71.23%). Metabolic syndrome was diag-nosed in 63 pregnant women (35.0%), with predominance in the group with pre-eclampsia (49.31%). In 96.3% of the 107 pregnant women who had not pre-eclamp-sia, the cardiovascular risk was low, while 50.7% of the 73 pregnant women with pre-eclampsia had a moderate, high and very high cardiovascular risk.
Conclusions: Half of women with pre-eclampsia had moderate, high, and very high cardiovascular risk. A high prevalence of metabolic syndrome was found in women who had pre-eclampsia, with a statistically significant association between these variables. It means that pregnant women with metabolic syndrome criteria present cardiovascular risk and a high risk of pre-eclampsia.


REFERENCES

  1. López-Fuenzalida A, Illanes Aguilar L, Rodríguez Canales C, Contreras-Briceño F, Durán-Agüero S, Herrera-Valenzuela T, et al. Riesgo cardiometabo-lico y variación en el contenido graso/adiposo según el índice de masa corporal en niños de seis a nueve años. Nutr Hosp. 2019;36(2):379-86. [DOI]

  2. Caamaño Navarrete F, Alarcón Hormazábal M, Delgado Floody P. Niveles de obesidad, perfil me-tabólico, consumo de tabaco y presión arterial en jóvenes sedentarios. Nutr Hosp. 2015;32(5):2000-6.[DOI]

  3. Navia Bueno MP, Yaksic Feraude N, Aguilar Mer-cado X, Farah Bravo J, Chambi E, Mollinedo Ro-cha E, et al. Factores de riesgo asociados a síndro- me metabólico en población habitante de 3600 y 4100 m.s.n.m. Rev Méd La Paz. 2015;21(2):6-17.

  4. O'Neill S, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its asso-ciated pathologies. Obes Rev. 2015;16(1):1-12. [DOI]

  5. Fayfman M, Haw S. Diabetes in Racial and Ethnic Minorities in the United States: Individualizing Approaches to Diagnosis and Management. Curr Diabetes Rev. 2017;13(3):239-50. [DOI]

  6. Miguel Soca PE. Predictores de riesgo cardiome-tabólico. Rev Finlay [Internet]. 2015 [citado 5 Ene 2021];5(2):80-1. Disponible en:http://www.revfinlay.sld.cu/index.php/finlay/article/view/357/1393

  7. Castillo Hernández JL, Cuevas González MJ, Al-mar Galiana M, Romero Hernández EY. Síndrome metabólico, un problema de salud pública con di-ferentes definiciones y criterios. Rev Med UV. 2017;17(2):7-24.

  8. Armaza Céspedes AX, Chambi Cayo TT, Mamani Ortiz Y, Abasto González S, Luizaga López JM. Factores de riesgo nutricionales asociados al sín-drome metabólico en personal militar de la Fuer-za Aérea de Cochabamba, Bolivia. Gac Méd Bo-liv. 2016;39(1):20-5.

  9. Suárez González JA, Gutiérrez Machado M. Ca-racterización del riesgo cardiometabolico en mu-jeres de edad mediana con antecedentes de preeclampsia en la última década. CorSalud [In-ternet]. 2019 [citado 6 Ene 2021];11(1):30-6. Dispo-nible en:http://www.revcorsalud.sld.cu/index.php/cors/article/view/407

  10. 10.Fernández Alba JJ, Mesa Páez C, Vilar Sánchez Á, Soto Pazos E, González Macías MC, Serrano Ne-gro E, et al. Sobrepeso y obesidad como factores de riesgo de los estados hipertensivos del emba-razo: estudio de cohortes retrospectivo. Nutr Hosp. 2018;35(4):874-80. [DOI]

  11. Johnsson IW, Haglund B, Ahlsson F, Gustafsson J. A high birth weight is associated with increased risk of type 2 diabetes and obesity. Pediatr Obes. 2015;10(2):77-83. [DOI]

  12. 12.WHO. Mortality Database [Internet]. Ginebra: OMS [citado 7 Ene 2021]; 2016. Disponible en:https://www.who.int/data/data-collection-tools/who-mortality-database

  13. 13.American Diabetes Association. Standards of medical care in diabetes-2015 abridged for prima-ry care providers. Clin Diabetes. 2015;33(2):97-111. [DOI]

  14. 14.Tangeras LH, Austdal M, Skrastad RB, Salvesen KA, Austgulen R, Bathen TF, et al. Distinct First Trimester Cytokine Profiles for Gestational Hyper-tension and Preeclampsia. Arterioscler Thromb Vasc Biol. 2015;35(11):2478-85. [DOI]

  15. 15.Schiavone M, Putoto G, Laterza F, Pizzol D. Gesta-tional diabetes: An overview with attention for developing countries. Endocr Regul. 2016;50(2): 62-71. [DOI]

  16. 16.Li X, Tan H, Huang X, Zhou S, Hu S, Wang X, et al. Similarities and differences between the risk fac-tors for gestational hypertension and preeclamp-sia: A population based cohort study in south Chi-na. Pregnancy Hypertens. 2016;6(1):66-71. [DOI]

  17. 17.Valdés G. Preeclampsia y enfermedad cardiovas-cular: un enfoque integral para detectar las fases subclínicas de complicaciones obstétricas y car-diovasculares. Rev Chil Cardiol. 2019;38(2):132-45. [DOI]

  18. 18.Organización Mundial de la Salud. Prevención delas enfermedades cardiovasculares: Guía de bolsillo para la estimación y el manejo del riesgo cardiovascular. Ginebra: OMS [Internet]; 2008 [ci-tado 9 Ene 2021]. Disponible en:https://apps.who.int/iris/handle/10665/43847

  19. 19.Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive Disor-ders of Pregnancy: ISSHP Classification, Diagno-sis, and Management Recommendations for In-ternational Practice. Hypertension. 2018;72(1):24-43. [DOI]

  20. 20.Arabin B, Baschat AA. Pregnancy: An Underuti-lized Window of Opportunity to Improve Long-term Maternal and Infant Health-An Appeal for Continuous Family Care and Interdisciplinary Communication. Front Pediatr [Internet]. 2017 [ci-tado 10 Ene 2021];5:69. Disponible en:https://doi.org/10.3389/fped.2017.00069

  21. 21.Grandi SM, Filion KB, Yoon S, Ayele HT, Doyle CM, Hutcheon JA, et al. Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications. Circula-tion. 2019;139(8):1069-79. [DOI]




2020     |     www.medigraphic.com